BK-MDA

DB12809InvestigationalSmall molecule

BK-MDA has been used in trials studying the treatment of Bladder Exstrophy and Urinary Incontinence.

Chemical structure of BK-MDA
Formula / weight
C10H11NO3 · 193.202 g/mol (avg)

Resolves to

Compound
UNIIK0XHQ9FYT3CAS80535-73-5PubChem57465250
Structure
InChIKeyXDEZOLVDJWWXRG-UHFFFAOYSA-NSMILESCC(N)C(=O)C1=CC=C2OCOC2=C1
Targets
P21980TGM2P22735TGM1

What you can answer from here — as of July 07, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
3+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with BK-MDA, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In